Jay Watsky, MD
Endocrinology, Diabetes & Metabolism · Albany, NYNPI 1972500247
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $30,113 of the $38,318 with a category attached, or 78.6%. 30 manufacturers reported payments, led by Boehringer Ingelheim at 54.9% of the total. Reporting peaked in 2019 at $14,098 and has fallen 98.6% since, to $201 in 2024. Among endocrinology, diabetes & metabolism clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 393 payments — averaging $97.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$21K
- Lilly USA, LLC$11K
- Amgen$2K
- Novo Nordisk$955
- Insulet Corporation$781
- Medtronic$643
- plus $3K from 24 others
What the payments were for
- Consulting fees$4881%
- Speaking & faculty fees$30,11379%
- Travel & lodging$1,0733%
- Food & beverage$6,52717%
- Education$1170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 40 | $21,021 |
| Lilly USA, LLC | 58 | $10,620 |
| Amgen(2 entities) | 26 | $1,527 |
| Novo Nordisk | 68 | $955 |
| Insulet Corporation | 37 | $781 |
| Medtronic(2 entities) | 7 | $643 |
| AstraZeneca(2 entities) | 28 | $388 |
| AbbVie | 18 | $313 |
| Abbott | 14 | $287 |
| Ipsen Biopharmaceuticals, Inc | 14 | $268 |
| Dexcom, Inc. | 8 | $240 |
| Johnson & Johnson | 15 | $212 |
| Sanofi-aventis U.S. LLC | 15 | $176 |
| Corcept Therapeutics | 8 | $127 |
| Tandem Diabetes Care, Inc. | 1 | $125 |
| Pfizer | 7 | $123 |
| Radius Health, Inc. | 6 | $101 |
| BETA Bionics, Inc. | 1 | $80 |
| OPKO Pharmaceuticals, LLC | 3 | $55 |
| Mannkind Corporation | 4 | $53 |
| Merck | 3 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $31 |
| Lifescan, Inc. | 2 | $31 |
| IBSA Pharma Inc. | 2 | $26 |
| Rhythm Pharmaceuticals, Inc. | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| BD | 1 | $15 |
| Janssen Scientific Affairs, LLC | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$30,722
- TEPEZZA$1,200
- Minimed 670G System$241
- t-slim insulin pump$125
- DEXCOM G6 TRANSMITTER$121
- Minimed 770G System$119
How this compares
$38,318 in reported general payments places this provider in the 90th percentile of 804 endocrinology, diabetes & metabolism providers in New York.
See all endocrinology, diabetes & metabolism providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 13 | $235 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Albany
- Robert BuschAlbany$2.7M
- Gregg GeretyAlbany$345K
- Michael ShanikSmithtown$1.2M
- Ajay ChaudhuriBuffalo$888K
- Vinay KapoorManhasset$820K
- John BilezikianNew York$809K
- Barbara HirschManhasset$746K
- Martin GrajowerBronx$713K
- Anastasios ManessisNew York$656K
- Jonas LeibowitzYonkers$613K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.